相关实验视频
Updated: Jan 12, 2026

10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
15.0K
酒精消费者的酒精消费变化与肝肥胖症之间的关系:一项基于人口的大规模生物银行研究
Suosu Wei1,2, Honglin Luo1, Zhemin Liu3
1Institute of Oncology, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
Frontiers in nutrition
|November 3, 2025
概括
增加酒精摄入量显著增加患肝硬化症 (脂肪肝疾病) 的几率. 相反,减少酒精消费降低了这些可能性,强调了减少酒精摄入量对公共卫生战略的重要性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 饮酒量变化与脂肪肝疾病之间的联系尚不清楚.
- 调查这种关系对于公共卫生干预至关重要.
研究的目的:
- 评估酒精消费模式的变化与肝硬化症的发展之间的关联.
- 分析来自大量饮酒者群体的数据.
主要方法:
- 包括33,427名参与者,具有基线和随访酒精消费数据.
- 将酒精摄入量分类为轻度,中度或重度.
- 使用磁共振成像 (MR) 评估肝脏肥胖症.
主要成果:
- 27.3%的参与者患有肝硬化症.
- 增加的酒精摄入量与更高的肝脏肥胖症的几率相关.
- 降低酒精摄入量与较低的肝脏肥胖症的几率相关.
- 男性,年轻人 (<65岁),体重指数较高的人以及高血压患者的敏感性增加.
结论:
- 高度饮酒会增加肝硬化风险;减少饮酒会降低风险.
- 公共卫生倡议应优先考虑减少饮酒量,以减轻脂肪肝疾病的负担.
相关概念视频
Hypothesis Test for Test of Independence
7.4K
The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
H0: The two variables (factors)...
7.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
245
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
245
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
164
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
164

